| 前收市價 | 1.1600 |
| 開市 | 1.1500 |
| 買盤 | 1.1000 x 200 |
| 賣出價 | 1.1600 x 200 |
| 今日波幅 | 1.1200 - 1.1500 |
| 52 週波幅 | 0.4700 - 1.8230 |
| 成交量 | |
| 平均成交量 | 417,268 |
| 市值 | 42.119M |
| Beta 值 (5 年，每月) | 2.65 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.2800 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 5.30 |
InvestorPlace3 Top Penny Stocks to Buy for Explosive Returns: April Edition
Some of the top penny stocks to buy can be rewarding. First, when it comes to penny stocks, you have to understand the high risk involved. As the U.S. Securities and Exchange Commission (SEC) states, “Penny stocks may trade infrequently — which means that it may be difficult to sell penny stock shares once you have them. Because it may also be difficult to find quotations for penny stocks, they may be impossible to accurately price. Investors in penny stock[s] should be prepared for the possibil
ZacksUnicycive (UNCY) Up on Positive Hyperphosphatemia Study Update
Unicycive (UNCY) rises after the encouraging progress in the late-stage development of its lead candidate, OLC, for the hyperphosphatemia indication. The NDA submission is expected around mid-2024.
